TY - STD TI - Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. U. S. Department of Health and Human Services (DHHS). 2008, [http://AIDSinfo.nih.gov] UR - http://AIDSinfo.nih.gov ID - ref1 ER - TY - JOUR AU - Renaud-Thery, F. AU - Nguimfack, B. D. AU - Vitoria, M. AU - Lee, E. AU - Graaff, P. AU - Samb, B. AU - Perriens, J. PY - 2007 DA - 2007// TI - Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens JO - Aids VL - 21 UR - https://doi.org/10.1097/01.aids.0000279711.54922.f0 DO - 10.1097/01.aids.0000279711.54922.f0 ID - Renaud-Thery2007 ER - TY - JOUR AU - Lawn, S. D. AU - Myer, L. AU - Bekker, L. G. AU - Wood, R. PY - 2006 DA - 2006// TI - Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control JO - Aids VL - 20 UR - https://doi.org/10.1097/01.aids.0000238406.93249.cd DO - 10.1097/01.aids.0000238406.93249.cd ID - Lawn2006 ER - TY - JOUR AU - Manosuthi, W. AU - Chottanapand, S. AU - Thongyen, S. AU - Chaovavanich, A. AU - Sungkanuparph, S. PY - 2006 DA - 2006// TI - Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy JO - J Acquir Immune Defic Syndr VL - 43 UR - https://doi.org/10.1097/01.qai.0000230521.86964.86 DO - 10.1097/01.qai.0000230521.86964.86 ID - Manosuthi2006 ER - TY - JOUR AU - Cohen, K. AU - van Cutsem, G. AU - Boulle, A. AU - McIlleron, H. AU - Goemaere, E. AU - Smith, P. J. AU - Maartens, G. PY - 2008 DA - 2008// TI - Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis JO - J Antimicrob Chemother VL - 61 UR - https://doi.org/10.1093/jac/dkm484 DO - 10.1093/jac/dkm484 ID - Cohen2008 ER - TY - JOUR AU - van Oosterhout, J. J. AU - Kumwenda, J. J. AU - Beadsworth, M. AU - Mateyu, G. AU - Longwe, T. AU - Burger, D. M. AU - Zijlstra, E. E. PY - 2007 DA - 2007// TI - Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians JO - Antivir Ther VL - 12 ID - van Oosterhout2007 ER - TY - JOUR AU - Dean, G. L. AU - Back, D. J. AU - de Ruiter, A. PY - 1999 DA - 1999// TI - Effect of tuberculosis therapy on nevirapine trough plasma concentrations JO - Aids VL - 13 UR - https://doi.org/10.1097/00002030-199912030-00029 DO - 10.1097/00002030-199912030-00029 ID - Dean1999 ER - TY - JOUR AU - Ribera, E. AU - Pou, L. AU - Lopez, R. M. AU - Crespo, M. AU - Falco, V. AU - Ocana, I. AU - Ruiz, I. AU - Pahissa, A. PY - 2001 DA - 2001// TI - Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis JO - J Acquir Immune Defic Syndr VL - 28 UR - https://doi.org/10.1097/00042560-200112150-00007 DO - 10.1097/00042560-200112150-00007 ID - Ribera2001 ER - TY - JOUR AU - Oliva, J. AU - Moreno, S. AU - Sanz, J. AU - Ribera, E. AU - Molina, J. A. AU - Rubio, R. AU - Casas, E. AU - Marino, A. PY - 2003 DA - 2003// TI - Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosis JO - Aids VL - 17 UR - https://doi.org/10.1097/00002030-200303070-00024 DO - 10.1097/00002030-200303070-00024 ID - Oliva2003 ER - TY - JOUR AU - Autar, R. S. AU - Wit, F. W. AU - Sankote, J. AU - Mahanontharit, A. AU - Anekthananon, T. AU - Mootsikapun, P. AU - Sujaikaew, K. AU - Cooper, D. A. AU - Lange, J. M. AU - Phanuphak, P. PY - 2005 DA - 2005// TI - Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis JO - Antivir Ther VL - 10 ID - Autar2005 ER - TY - JOUR AU - Manosuthi, W. AU - Mankatitham, W. AU - Lueangniyomkul, A. AU - Chimsuntorn, S. AU - Sungkanuparph, S. PY - 2008 DA - 2008// TI - Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin JO - HIV Med VL - 9 UR - https://doi.org/10.1111/j.1468-1293.2008.00563.x DO - 10.1111/j.1468-1293.2008.00563.x ID - Manosuthi2008 ER - TY - JOUR AU - Manosuthi, W. AU - Sungkanuparph, S. AU - Thakkinstian, A. AU - Rattanasiri, S. AU - Chaovavanich, A. AU - Prasithsirikul, W. AU - Likanonsakul, S. AU - Ruxrungtham, K. PY - 2006 DA - 2006// TI - Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin JO - Clin Infect Dis VL - 43 UR - https://doi.org/10.1086/505210 DO - 10.1086/505210 ID - Manosuthi2006 ER - TY - JOUR AU - Veen, J. AU - Raviglione, M. AU - Rieder, H. L. AU - Migliori, G. B. AU - Graf, P. AU - Grzemska, M. AU - Zalesky, R. PY - 1998 DA - 1998// TI - Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients JO - Eur Respir J VL - 12 UR - https://doi.org/10.1183/09031936.98.12020505 DO - 10.1183/09031936.98.12020505 ID - Veen1998 ER - TY - JOUR AU - Launay, O. AU - Roudiere, L. AU - Boukli, N. AU - Dupont, B. AU - Prevoteau du Clary, F. AU - Patey, O. AU - David, F. AU - Lortholary, O. AU - Devidas, A. AU - Piketty, C. PY - 2004 DA - 2004// TI - Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial JO - Clin Infect Dis VL - 38 UR - https://doi.org/10.1086/382677 DO - 10.1086/382677 ID - Launay2004 ER - TY - JOUR AU - Tashima, K. AU - Staszewski, S. AU - Nelson, M. AU - Rachlis, A. AU - Skiest, D. AU - Stryker, R. AU - Bessen, L. AU - Overfield, S. AU - Ruiz, N. AU - Wirtz, V. PY - 2008 DA - 2008// TI - Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection JO - Aids VL - 22 UR - https://doi.org/10.1097/QAD.0b013e3282f21b9d DO - 10.1097/QAD.0b013e3282f21b9d ID - Tashima2008 ER - TY - JOUR AU - Reliquet, V. AU - Allavena, C. AU - Francois-Brunet, C. AU - Perre, P. AU - Bellein, V. AU - Garre, M. AU - May, T. AU - Souala, F. AU - Besnier, J. M. AU - Raffi, F. PY - 2006 DA - 2006// TI - Long-term assessment of nevirapine-containing highly active antiretroviral therapy in antiretroviral-naive HIV-infected patients: 3-year follow-up of the VIRGO study JO - HIV Med VL - 7 UR - https://doi.org/10.1111/j.1468-1293.2006.00402.x DO - 10.1111/j.1468-1293.2006.00402.x ID - Reliquet2006 ER - TY - CHAP AU - de Beaudrap, P. AU - Etard, J. F. AU - Gueye, F. N. AU - Gueye, M. AU - Landman, R. AU - Girard, P. M. AU - Sow, P. S. AU - Ndoye, I. AU - Delaporte, E. PY - 2008 DA - 2008// TI - Long-Term Efficacy and Tolerance of Efavirenz- and Nevirapine-Containing Regimens in Adult HIV Type 1 Senegalese Patients BT - AIDS Res Hum Retroviruses ID - de Beaudrap2008 ER - TY - JOUR AU - Manosuthi, W. AU - Ruxrungtham, K. AU - Likanonsakul, S. AU - Prasithsirikul, W. AU - Inthong, Y. AU - Phoorisri, T. AU - Sungkanuparph, S. PY - 2007 DA - 2007// TI - Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/510078 DO - 10.1086/510078 ID - Manosuthi2007 ER - TY - JOUR AU - McComsey, G. AU - Lonergan, J. T. PY - 2004 DA - 2004// TI - Mitochondrial dysfunction: patient monitoring and toxicity management JO - J Acquir Immune Defic Syndr VL - 37 UR - https://doi.org/10.1097/01.qai.0000137004.63376.27 DO - 10.1097/01.qai.0000137004.63376.27 ID - McComsey2004 ER - TY - JOUR AU - Vella, S. AU - Giuliano, M. AU - Dally, L. G. AU - Agresti, M. G. AU - Tomino, C. AU - Floridia, M. AU - Chiesi, A. AU - Fragola, V. AU - Moroni, M. AU - Piazza, M. PY - 1994 DA - 1994// TI - Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group JO - J Acquir Immune Defic Syndr VL - 7 ID - Vella1994 ER - TY - STD TI - Scaling up Antiretroviral Therapy in Resource-limited Settings: Treatment Guidelines for a public Health Approach. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO), 2006 revision ID - ref21 ER - TY - JOUR AU - Penzak, S. R. AU - Kabuye, G. AU - Mugyenyi, P. AU - Mbamanya, F. AU - Natarajan, V. AU - Alfaro, R. M. AU - Kityo, C. AU - Formentini, E. AU - Masur, H. PY - 2007 DA - 2007// TI - Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda JO - HIV Med VL - 8 UR - https://doi.org/10.1111/j.1468-1293.2007.00432.x DO - 10.1111/j.1468-1293.2007.00432.x ID - Penzak2007 ER - TY - JOUR AU - Wyen, C. AU - Hendra, H. AU - Vogel, M. AU - Hoffmann, C. AU - Knechten, H. AU - Brockmeyer, N. H. AU - Bogner, J. R. AU - Rockstroh, J. AU - Esser, S. AU - Jaeger, H. PY - 2008 DA - 2008// TI - Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients JO - J Antimicrob Chemother VL - 61 UR - https://doi.org/10.1093/jac/dkn029 DO - 10.1093/jac/dkn029 ID - Wyen2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/8/136/prepub UR - http://www.biomedcentral.com/1471-2334/8/136/prepub ID - ref24 ER -